Dipeptidyl peptidase-4 inhibitors and osteoporosis

被引:8
|
作者
Lee, Wen-Ling [1 ,2 ,3 ]
Lee, Fa-Kung [4 ,5 ]
Wang, Peng-Hui [2 ,5 ,6 ,7 ]
机构
[1] Cheng Hsin Gen Hosp, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[3] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan
[4] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[5] Female Canc Fdn, Taipei, Taiwan
[6] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, 201,Sect 2,Shi Pai Rd, Taipei 112, Taiwan
[7] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
关键词
RISK; NATIONWIDE; OUTCOMES; CARE;
D O I
10.1097/JCMA.0000000000000775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:889 / 890
页数:2
相关论文
共 50 条
  • [41] Interstitial pneumonia during administration of dipeptidyl peptidase-4 inhibitors
    Tagaya, Yuko
    Okada, Shuichi
    Hisada, Takashi
    Niijima, Yawara
    Yamada, Masanobu
    JOURNAL OF DIABETES, 2016, 8 (03) : 442 - 442
  • [42] Potential role of dipeptidyl peptidase-4 inhibitors in atrial fibrillation
    Zhang, Xiaowei
    Zhang, Zhiwei
    Li, Mingzhen
    Li, Guangping
    Liu, Tong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 207 : 46 - 47
  • [43] Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach
    Yao Dai
    Dongsheng Dai
    Federico Mercanti
    Zufeng Ding
    Xianwei Wang
    Jawahar L. Mehta
    Acta Diabetologica, 2013, 50 : 827 - 835
  • [44] Dipeptidyl Peptidase-4 Inhibitors and Heart Failure: Friends or Foes?
    Monami M.
    Mannucci E.
    Current Cardiovascular Risk Reports, 2015, 9 (8)
  • [45] Dipeptidyl peptidase-4 inhibitors -: Clinical data and clinical implications
    Ahren, Bo
    DIABETES CARE, 2007, 30 (06) : 1344 - 1350
  • [46] Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
    Mulvihill, Erin E.
    Drucker, Daniel J.
    ENDOCRINE REVIEWS, 2014, 35 (06) : 992 - 1019
  • [47] DIPEPTIDYL PEPTIDASE-4 INHIBITORS, SULPHONYLUREAS, AND HYPOGLYCAEMIA Under-representation of frail older people in meta-analysis of dipeptidyl peptidase-4 inhibitors and hypoglycaemia
    Tufan, Fatih
    Soyluk, Ozlem
    Bahat, Gulistan
    Karan, Mehmet Akif
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 353
  • [48] Erratum to: Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
    Larry K. Golightly
    Caitlin C. Drayna
    Michael T. McDermott
    Clinical Pharmacokinetics, 2012, 51 : 831 - 831
  • [49] Dipeptidyl Peptidase-4 Inhibitors Do Not Exacerbate Heart Failure
    Kanmanthareddy, Arun
    Koripalli, Sandeep
    Buddam, Avanija R.
    Reddy, Madhu
    Vallakati, Ajay
    Bommana, Sudharani
    Atkins, Donita
    Lakkireddy, Dhanunjaya
    JOURNAL OF CARDIAC FAILURE, 2014, 20 (08) : S47 - S47
  • [50] Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach
    Dai, Yao
    Dai, Dongsheng
    Mercanti, Federico
    Ding, Zufeng
    Wang, Xianwei
    Mehta, Jawahar L.
    ACTA DIABETOLOGICA, 2013, 50 (06) : 827 - 835